Martini Alberto
Podsumowanie dorobku w bazie danych
8
publikacji (2013–2015)
12,384
łączny Impact Factor
45
łącznie punktów MNiSW
Identyfikatory
PBN
Profil w PBN BPP ID
29570Publikacje w latach
50
Punkty MNiSW w latach
45,000
Impact Factor w latach
12,3840
Statystyki wg charakteru
| Charakter formalny | Liczba prac |
|---|---|
| 7 | |
| 1 | |
| Razem | 8 |
Wyszukaj publikacje autora
Bez zaznaczonych filtrów wyszukiwanie pokaże wszystkie prace autora. Zaznacz typy, lata lub jednostki, żeby zawęzić wyniki.
Eksport publikacji
Najlepsze prace (punkty MNiSW)
- Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial. [AUT. KORESP.] HERMINE I. BRUNNER, [AUT.] NICOLINO RUPERTO, ZBIGNIEW ZUBER, CAROLINE KEANE, OLIVIER HARARI, ANDREW KENWRIGHT, PENG LU, RUBEN CUTTICA, VLADIMIR KELTSEV, RICARDO M. XAVIER, INMACULADA CALVO, IRINA NIKISHINA, NADINA RUBIO-PÉREZ, EKATERINA ALEXEEVA, VYACHESLAV CHASNYK, GERD HORNEFF, VIOLETTA OPOKA-WINIARSKA, PIERRE QUARTIER, CLOVIS A. SILVA, EARL SILVERMAN, ALBERTO SPINDLER, EILEEN BAILDAM, M. LUZ GÁMIR, ALAN MARTIN, CHRISTOPH RIETSCHEL, DANIEL SIRI, ELŻBIETA SMOLEWSKA, DANIEL LOVELL, ALBERTO MARTINI, FABRIZIO DE BENEDETTI, FOR THE PAEDIATRIC RHEUMATOLOGY INTERNATIONAL TRIALS ORGANISATION (PRINTO), THE PEDIATRIC RHEUMATOLOGY COLLABORATIVE STUDY GROUP (PRCSG). Ann. Rheum. Dis. 2015 vol. 74 nr 6 s. 1110-1117, bibliogr. poz. 22. DOI: 10.1136/annrheumdis-2014-205351
Najlepsze prace (Impact Factor)
- Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial. [AUT. KORESP.] HERMINE I. BRUNNER, [AUT.] NICOLINO RUPERTO, ZBIGNIEW ZUBER, CAROLINE KEANE, OLIVIER HARARI, ANDREW KENWRIGHT, PENG LU, RUBEN CUTTICA, VLADIMIR KELTSEV, RICARDO M. XAVIER, INMACULADA CALVO, IRINA NIKISHINA, NADINA RUBIO-PÉREZ, EKATERINA ALEXEEVA, VYACHESLAV CHASNYK, GERD HORNEFF, VIOLETTA OPOKA-WINIARSKA, PIERRE QUARTIER, CLOVIS A. SILVA, EARL SILVERMAN, ALBERTO SPINDLER, EILEEN BAILDAM, M. LUZ GÁMIR, ALAN MARTIN, CHRISTOPH RIETSCHEL, DANIEL SIRI, ELŻBIETA SMOLEWSKA, DANIEL LOVELL, ALBERTO MARTINI, FABRIZIO DE BENEDETTI, FOR THE PAEDIATRIC RHEUMATOLOGY INTERNATIONAL TRIALS ORGANISATION (PRINTO), THE PEDIATRIC RHEUMATOLOGY COLLABORATIVE STUDY GROUP (PRCSG). Ann. Rheum. Dis. 2015 vol. 74 nr 6 s. 1110-1117, bibliogr. poz. 22. DOI: 10.1136/annrheumdis-2014-205351
Najnowsze artykuły
- Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial. [AUT. KORESP.] HERMINE I. BRUNNER, [AUT.] NICOLINO RUPERTO, ZBIGNIEW ZUBER, CAROLINE KEANE, OLIVIER HARARI, ANDREW KENWRIGHT, PENG LU, RUBEN CUTTICA, VLADIMIR KELTSEV, RICARDO M. XAVIER, INMACULADA CALVO, IRINA NIKISHINA, NADINA RUBIO-PÉREZ, EKATERINA ALEXEEVA, VYACHESLAV CHASNYK, GERD HORNEFF, VIOLETTA OPOKA-WINIARSKA, PIERRE QUARTIER, CLOVIS A. SILVA, EARL SILVERMAN, ALBERTO SPINDLER, EILEEN BAILDAM, M. LUZ GÁMIR, ALAN MARTIN, CHRISTOPH RIETSCHEL, DANIEL SIRI, ELŻBIETA SMOLEWSKA, DANIEL LOVELL, ALBERTO MARTINI, FABRIZIO DE BENEDETTI, FOR THE PAEDIATRIC RHEUMATOLOGY INTERNATIONAL TRIALS ORGANISATION (PRINTO), THE PEDIATRIC RHEUMATOLOGY COLLABORATIVE STUDY GROUP (PRCSG). Ann. Rheum. Dis. 2015 vol. 74 nr 6 s. 1110-1117, bibliogr. poz. 22. DOI: 10.1136/annrheumdis-2014-205351
Ostatnio edytowane
- Pharmacokinetics (PK) and pharmacodynamics (PD) of tocilizumab (TCZ) in polyarticular-course juvenile idiopathic arthritis (pcJIA). [AUT.] X. ZHANG, J. HSU, H. BRUNNER, F. DE BENEDETTI, C. LE GALLO, Z. ZUBER, R. CUTTICA, V. KELTSEV, R. XAVIER, I. C. PENEDES, N. RUBIO-PÉREZ, V. CHASNYK, G. HORNEFF, V[IOLETTA] OPOKA-WINIARSKA, P. QUARTIER, C. SILVA, A. SPINDLER, E. BAILDAM, M. L. GAMIR, A. MARTIN, D. A. SIRI, E. SMOLEWSKA, D. LOVELL, N. RUPERTO, A. MARTINI. Clin. Pharmacol. Ther. 2013 vol. 93 nr S1 s. S88-S89, Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics (ASCPT) : Quantitative systems pharmacology an integrating framework for translational medicine pre-conference. Indianapolis, March, 05-09, 2013. [Abstr.]. DOI: 10.1038/clpt.2012.258
- Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: 2-year data from Cherish. [AUT.] HERMINE I. BRUNNER, NICOLINO RUPERTO, ZBIGNIEW ZUBER, RUBEN J.CUTTICA, RICARDO XAVIER, INMACULADA CALVO, NADINA RUBIO, EKATERINA ALEKSEEVA, VYACHESLAV CHASNYK, JOSE CHAVEZ, GERD HORNEFF, V[IOLETTA] OPOKA-WINIARSKA, PIERRE QUARTIER, ALBERTO SPINDLER, CAROLINE KEANE, KAMAL N. BHARUCHA, JIANMEI WANG, DANIEL J. LOVEL, ALBERTO MARTINI, FABRIZIO DE BENEDETT. Arthr. Rheum. 2013 vol. 65 nr 10 suppl. s. S335, 2013 Annual Meeting. San Diego, October 25-30, 2013. Abstr.
- PReS-FINAL-2180: Efficacy and safety of tocilizumab (TCZ) in patients with polyarticular-course juvenile idiopathic arthritis (pcJIA): 2-year data from CHERISH. [AUT.] F. DE BENEDETTI, N. RUPERTO, Z. ZUBER, R. CUTTICA, R. XAVIER, I. CALVO, N. RUBIO, E. ALEKSEEVA, V. CHASNYK, J. CHAVEZ, G. HORNEFF, V[IOLETTA] OPOKA-WINIARSKA, P. QUARTIER, A. SPINDLER, C. KEANE, K. BHARUCHA, J. WANG, D. LOVELL, A. MARTINI, HI. BRUNNER. Pediatr. Rheumatol. 2013 vol. 11 suppl. 2 [b. pag.] O15, Proceedings of 20th Pediatric Rheumatology European Society (PReS) Congress. Ljubljana, 25-29 September 2013. Abstr.
- Efficacy and safety of tocilizumab in patients with polyarticular juvenile idiopathic arthritis: data from a phase 3 trial. [AUT.] F. DE BENEDETTI, N. RUPERTO, Z. ZUBER, C. KEANE, O. HARARI, A. KENWRIGHT, R. CUTTICA, V. KELTSEV, R. XAVIER, I. CALVO, I. NIKISHINA, N. RUBIO-PÉREZ, E. ALEKSEEVA, V. CHASNYK, J. CHAVEZ, G. HORNEFF, V[IOLETTA] OPOKA-WINIARSKA, P. QUARTIER, C. SILVA, E. SILVERMAN, A. SPINDLER, A. MARTINI, D. LOVELL, H. BRUNNER. Ann. Rheum. Dis. 2013 vol. 72 suppl. 3 s. 70, Annual European Congress of Rheumatology EULAR 2013. Madrid, 12-15 June 2013. Abstr.
- Efficacy and safety of tocilizumab in patients with polyarticular-course juvenile idiopathic arthritis: results from a phase 3, randomised, double-blind withdrawal trial. [AUT. KORESP.] HERMINE I. BRUNNER, [AUT.] NICOLINO RUPERTO, ZBIGNIEW ZUBER, CAROLINE KEANE, OLIVIER HARARI, ANDREW KENWRIGHT, PENG LU, RUBEN CUTTICA, VLADIMIR KELTSEV, RICARDO M. XAVIER, INMACULADA CALVO, IRINA NIKISHINA, NADINA RUBIO-PÉREZ, EKATERINA ALEXEEVA, VYACHESLAV CHASNYK, GERD HORNEFF, VIOLETTA OPOKA-WINIARSKA, PIERRE QUARTIER, CLOVIS A. SILVA, EARL SILVERMAN, ALBERTO SPINDLER, EILEEN BAILDAM, M. LUZ GÁMIR, ALAN MARTIN, CHRISTOPH RIETSCHEL, DANIEL SIRI, ELŻBIETA SMOLEWSKA, DANIEL LOVELL, ALBERTO MARTINI, FABRIZIO DE BENEDETTI, FOR THE PAEDIATRIC RHEUMATOLOGY INTERNATIONAL TRIALS ORGANISATION (PRINTO), THE PEDIATRIC RHEUMATOLOGY COLLABORATIVE STUDY GROUP (PRCSG). Ann. Rheum. Dis. 2015 vol. 74 nr 6 s. 1110-1117, bibliogr. poz. 22. DOI: 10.1136/annrheumdis-2014-205351
Osadź publikacje tego autora na swojej stronie WWW — kliknij tutaj.